Kinetics Medical Fund Class A (KRXAX)

24.75
Net Asset Value
-0.48%
1 Day
+1.73%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
5.75
Sales Expenses
2.33%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio- a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks- convertible securities- warrants- and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research- pharmaceutical and medical technology industries and related technology industries- with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Performance

1 month-1.78% 3 years+0.65%
3 months+4.55% 5 years+11.46%
1 year+8.13% Since inception+6.13%
Data through --

Peer Comparisonvs. Health

 KRXAXCategory
Performance 5-yr return+11.46%+17.28%
Expense ratio2.33%1.31%
Risk 5 year sharpe ratio0.861.11
Net assets$20.1M$3.2B
Average market cap$70.4B$9.5B
Average P/E24.522.6
Portfolio turnover0%0%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyKinetics
Fund manager & tenureBruce Abel / 18 Years
Minimal initial investment$2,500.00
Minimum IRA investment$2,500.00

Holdings

U.S. stock67.13%
International stock26.81%
Cash6.01%
Fixed income0.05%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 94.65%
Industrial materials 4.23%
Business service 1.12%
Telecommunication 0.01%
Consumer goods 0.00%
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co7.81%
PFE Pfizer7.38%
BMY Bristol-Myers Squibb7.36%
SNY Sanofi5.99%
NVS Novartis5.78%
BIIB Biogen5.65%
JNJ Johnson & Johnson5.63%
ABBV AbbVie5.55%
ALKS Alkermes Plc5.38%
CELG Celgene4.91%